Cover Image


2015 Gene Expression Profiling Dashboard Series 5 - NA and EU

出版商 Percepta Associates Inc. 商品編碼 230088
出版日期 內容資訊 英文 135 Pages
商品交期: 最快1-2個工作天內
Back to Top
基因表達譜的儀表板系列5:北美、歐洲 2015 Gene Expression Profiling Dashboard Series 5 - NA and EU
出版日期: 2015年04月27日 內容資訊: 英文 135 Pages

本報告以北美、歐洲的382個科學家的基因表達譜 (GEP) 手法相關問卷調查結果為基礎,提供整體市場/各分類市場的主要指標相關驗證、新產品、新加入企業、新的銷售與行銷策略等,系統性資訊。


  • 摘要整理
  • 受訪者的必要條件
  • 人口統計
  • 實施頻率:生命科學技術
  • 實施頻率:基因表達譜相關技術
  • 共同實施:基因表達譜相關、生命科學技術
  • 實驗單位的容許量
  • 各反應的出示價格/實驗單位數量的變化預測/供應商佔有率
  • 市場規模
  • 對顧客滿意度與供應商變更的關注
  • 購買意願決策要素:產品的特徵
  • 一次、二次的下游應用
  • 實施的分析種類
  • 對產品期望的變更
  • 產品的未滿足需求
  • 附錄


Product Code: 1504GEP

Gene expression profiling (GEP) methods enable the quantification of multiple transcripts from a single RNA sample. Powerful and continually evolving methods, such as short-read sequencing (RNA-seq), microarray analysis, quantitative real-time RT-PCR, as well as traditional methods for differential gene expression studies using multiplex endpoint PCR and northern blot analysis are employed by scientists to analyze gene function, identify new therapeutic and diagnostic targets, and to map pathways involved in development and disease.

Percepta's 2015 Gene Expression Profiling Dashboard™ is the fifth in a series that characterizes the dynamic market for products for profiling gene expression. This 2015 Dashboard provides a snapshot of the current market landscape that is compared with data from the 2012 and in some cases 2010 and 2008 Gene Expression Profiling Dashboards, providing an ongoing picture of how the market is adapting to new products, new competitors and new sales and marketing strategies.

The 2015 Gene Expression Profiling Dashboard™ was developed from responses to a 21-question survey completed by 382 scientists located in North America and Europe. These respondents perform gene expression profiling methods on a regular basis. This dashboard reveals key market indicators for the gene expression profiling market as a whole as well as for the following methods representing market sub-segments:

  • Differential gene expression studies using multiplex endpoint PCR
  • Digital gene expression/molecular barcodes
  • Microarray-based gene expression studies (including bead arrays)
  • qRT-PCR (cDNA template) using gene specific fluorescent probe
  • qRT-PCR (cDNA template) using non-specific SYBR Green
  • Northern blot analysis
  • Serial analysis of gene expression studies
  • Transcriptome studies using tiling arrays
  • Transcriptome studies via (RNA-seq) short-read sequencing

List of Companies Surveyed

Please note that respondents were provided with an option to list other suppliers.

  • Affymetrix/eBiosciences
  • Agilent Technologies
  • Bio-Rad
  • Clontech/TAKARA
  • GE Healthcare
  • IDT (Integrated DNA Technology)
  • Illumina
  • Luminex
  • Nanostring
  • New England Biolabs
  • NimbleGen/Roche Applied Sciences
  • Promega
  • Qiagen/Pacific Biosciences
  • Sigma-Aldrich
  • SuperArray Biosciences
  • Thermo Fisher Scientific (includes Life Technologies)
  • Homemade reagents

Table of Contents

  • Executive Summary
    • Dashboard "At a Glance"
    • Market Opportunity Matrix
  • Respondents Qualification
  • Demographics
  • Frequency of Performance: Life Science Techniques
  • Frequency of Performance: Gene Expression Profiling-Related Techniques
  • Co-Performance: Gene Expression Profiling-Related & Life Science Techniques
  • Experimental Unit Throughput
  • Stated Price per Reaction/Expected Change in Experimental Unit Volume/Supplier Share
  • Market Size
  • Customer Satisfaction & Interest in Switching
  • Purchase Decision Factors: Product Features
  • Primary & Secondary Downstream Applications
  • Types of Analyses Performed
  • Desired Product Changes
  • Unmet Product Needs
  • Appendix I: Supporting Data
  • Appendix II: Percepta Capabilities and Life Science Dashboards™ Available
Back to Top